Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Impact of Real-time Continuous Glucose Monitoring on Glycaemic Control in High-risk Adolescents and Young Adults With Insulin-treated Diabetes

NCT04039763 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04039763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04039763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Impact of Real-time Continuous Glucose Monitoring on Glycaemic Control in High-risk Adolescents and Young Adults With Insulin-treated Diabetes
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Recruiting
Start date
September 3, 2020
Completion date
June 30, 2022
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, diabetes mellitus, diabetes mellitus, type 1, endocrine system diseases, glucose metabolism disorders, metabolic disease